Daily Archives: July 11, 2019

American Gastroenterological Association Guideline on Mild-to-Moderate Ulcerative Colitis on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)

Posted on July 11, 2019 by Gastroenterology Journal

This document presents the official recommendations of the American Gastroenterological Association (AGA) on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults. The guideline was develop… Continue reading →

Posted in News | Comments Off on American Gastroenterological Association Guideline on Mild-to-Moderate Ulcerative Colitis on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D)

Reply to GASTRO-D-19-01131

Posted on July 11, 2019 by Gastroenterology Journal
Posted in News | Comments Off on Reply to GASTRO-D-19-01131

Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps

Posted on July 11, 2019 by Gastroenterology Journal

Endoscopic screening reduces incidence and mortality of colorectal cancer (CRC) because precursor lesions, such as conventional adenomas or serrated polyps, are removed. Individuals with polypectomies are advised to undergo colonoscopy surveillance to … Continue reading →

Posted in News | Comments Off on Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps

Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice

Posted on July 11, 2019 by Gastroenterology Journal

It is not clear how regulation of T-cell function is altered during development of inflammatory bowel diseases (IBD). We studied the mechanisms by which geranylgeranyltransferase-mediated prenylation controls T-cell localization to the intestine and ch… Continue reading →

Posted in News | Comments Off on Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice

Development and Validation of Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 months for Patients With Suspected Drug-Induced Liver Injury

Posted on July 11, 2019 by Gastroenterology Journal

Patients with drug-induced liver injury (DILI) frequently have comorbid conditions, but the effects of non-liver comorbidities on outcome is not well understood. We investigated the association between co-morbidity burden and outcomes of patients with … Continue reading →

Posted in News | Comments Off on Development and Validation of Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 months for Patients With Suspected Drug-Induced Liver Injury